Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Louis Picker
Oregon Health & Science University, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vir Biotechnology, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached pdf
Antibody-Based Enhancement of CMV Vaccine Vectors for HIV
PROJECT NARRATIVE Rhesus CMV vaccine vectors expressing SIV antigens lead to stringent control of SIV replication in 50% of vaccinated macaques via induction of effector memory T cells. Here we propose to study the correlation between CD4+ T cells and CMV vaccine-mediated control of post-infection SHIV replication. Further, we will assess whether CMV vaccine vectors for HIV can be enhanced by addition of HIV-Env DNA and protein immunizations designed to elicit Env-specific antibodies.
Filed on September 05, 2018.
Tell us what you know about Louis Picker's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Louis Picker”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Louis Picker | Oregon Health & Science University | Conflict of Interest | Vir Biotechnology, Inc. | $0 - $4,999 |
| Louis Picker | University of California, San Francisco | Conflict of Interest | TomegaVax, Inc. | $0 - $4,999 |
| Louis Picker | Beth Israel Deaconess Medical Center | Conflict of Interest | Vir Biotechnology, Inc | $0 - $4,999 |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | Vir Biotechnology, Inc. | $150,000 - $199,999 |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | TomegaVax | Value cannot be readily determined |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | TomegaVax | $0 - $4,999 |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | VirBio | Value cannot be readily determined |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | TomegaVax, Inc. | $0 - $4,999 |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | Vir Biotechnologies, Inc. | $150,000 - $199,999 |
| Louis Picker | Oregon Health & Science University | Conflict of Interest | TomegaVax, Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.